Citations

Mayo Clinic

Showing 10 of 108551 citations.

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential
Bieghs, Liesbeth, Johnsen, Hans Erik , Maes, Ken , Menu, Eline , Valckenborgh, Els Van , Overgaard, Michael T. , Nyegaard, Mette , Conover, Cheryl A. , Vanderkerken, Karin , Bruyne, Elke De

Oncotarget | April 25, 2016 | Volume: 7 | Issue: 30 | Pages: 48732-48752

10.18632/oncotarget.8982 | PMID 27129151 Get It

Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism
Maraka, Spyridoula , Ospina, Naykky Singh , O’Keeffe, Derek T. , Rodríguez‐Gutiérrez, René , Ycaza, Ana E. Espinosa De, Juhn, Young J. , Coddington, Charles C. , Montori, Víctor M. , Stan, Marius N. , Ospina, Naykky Singh , Singh Ospina, Naykky M, Espinosa De Ycaza, Ana E, Wi, Chung‐Il , Maraka, Spyridoula , Montori, Victor M , Stan, Marius N , Singh Ospina, Naykky

Thyroid® | April 25, 2016 | Volume: 26 | Issue: 7 | Pages: 980-986

10.1089/thy.2016.0014 | PMID 27112035 Get It

Background: Subclinical hypothyroidism (SCH) has been associated with increased risk of adverse pregnancy outcomes in some, but not all, studies. Uncertainty remains regarding the impact of levothyroxine (LT4) therapy on improving health outcomes in pregnant women with SCH. The objective of this study was to assess the potential benefits of LT4 therapy in pregnant women with SCH. Methods: The medical records were reviewed of pregnant women with SCH, defined as an elevated serum thyrotropin (TSH) of >2.5 mIU/L for the 1st trimester or >3 mIU/L for the 2nd and 3rd trimesters, but ≤10 mIU/L. Pregnant women were divided into two groups depending on whether they received LT4 (group A) or not (group B). Pregnancy loss and other pre-specified adverse outcomes were evaluated during follow-up. Results: There were 82 women in group A and 284 in group B. Group A had a higher body mass index ( p = 0.04) and a higher serum TSH level ( p < 0.0001) compared with group B. Group A had fewer pregnancies lost ( n = 5 [6.1%] vs. n = 25 [8.8%]; p = 0.12), low birth weight (LBW) offspring (1.3% vs. 10%; p < 0.001), and no neonates with a five-minute Apgar score ≤7 (0% vs. 7%; p < 0.001) compared with group B. Other pregnancy-related adverse outcomes were similar between the two groups. Inferences remained unchanged after considering different models to adjust for potential predictors of outcome. Conclusions: LT4 therapy is associated with a decreased risk of LBW and a low Apgar score among women with SCH. This association awaits confirmation in randomized trials before the widespread use of LT4 therapy in pregnant women with SCH.
Focal photoparoxysmal response in the Heidenhain variant of CJD
Feyissa, Anteneh M. , Wirrell, Elaine C., Young, Nathan P. , Wirrell, Elaine , Jones, David T. , Britton, Jeffrey W. , Feyissa, A M

Neurology | April 25, 2016 | Volume: 86 | Issue: 17 | Pages: 1647-1648

10.1212/wnl.0000000000002617 | PMID 27164643 Get It

Polyarthritis as a Rare Presentation of Hydroxyapatite Deposition Disease
Aslam, Fawad , Matteson, Eric L. , Aslam, Fawad

Arthritis & Rheumatology | April 25, 2016 | Volume: 68 | Issue: 8 | Pages: 2056-2056

10.1002/art.39717 | PMID 27111452 Get It

Editorial: The Multi‐Biomarker Disease Activity Test for Rheumatoid Arthritis: Is It a Valid Measure of Disease Activity?
Davis, John M. , Davis, John M

Arthritis & Rheumatology | April 25, 2016 | Volume: 68 | Issue: 9 | Pages: 2061-2066

10.1002/art.39716 | PMID 27111349 Get It

Isolated supra-cardiac partial anomalous pulmonary venous connection causing right heart failure
Sogomonian, Robert , Alkhawam, Hassan, Zaiem, Feras, Vyas, Neil , Jolly, J., Nguyen, James , Haftevani, Emma A. Moradoghli, Dijanic, Christopher , Lieber, Joseph

Journal of Community Hospital Internal Medicine Perspectives | April 25, 2016 | Volume: 6 | Issue: 2 | Pages: 30817

10.3402/jchimp.v6.30817 | PMID 27124165 Get It

An appraisal of published usability evaluations of electronic health records via systematic review
Ellsworth, Marc A., Dziadzko, Mikhail , O’Horo, John C. , Zhang, Jiajie , Herasevich, Vitaly , Farrell, Ann M, Farrell, Ann , O'Horo, John C , Herasevich, Vitaly

Journal of the American Medical Informatics Association | April 24, 2016 | Volume: 24 | Issue: 1 | Pages: 218-226

10.1093/jamia/ocw046 | PMID 27107451 Get It

Objective: In this systematic review, we aimed to evaluate methodological and reporting trends present in the current literature by investigating published usability studies of electronic health records (EHRs). Methods: A literature search was conducted for articles published through January 2015 using MEDLINE (Ovid), EMBASE, Scopus, and Web of Science, supplemented by citation and reference list reviews. Studies were included if they tested the usability of hospital and clinic EHR systems in the inpatient, outpatient, emergency department, or operating room setting. Results: A total of 4848 references were identified for title and abstract screening. Full text screening was performed for 197 articles, with 120 meeting the criteria for study inclusion. Conclusion: A review of the literature demonstrates a paucity of quality published studies describing scientifically valid and reproducible usability evaluations at various stages of EHR system development. A lack of formal and standardized reporting of EHR usability evaluation results is a major contributor to this knowledge gap, and efforts to improve this deficiency will be one step of moving the field of usability engineering forward.
An informatics research agenda to support precision medicine: seven key areas
Tenenbaum, Jessica D. , Avillach, Paul , Benham‐Hutchins, Marge , Breitenstein, Matthew K. , Crowgey, Erin L. , Hoffman, Mark A. , Jiang, Xia , Madhavan, Subha , Mattison, John , Nagarajan, Radhakrishnan , Ray, Bisakha, Shin, Dmitriy , Visweswaran, Shyam , Freimuth, Robert R. , Zhao, Zhongming , Hoffman, Mark A , Freimuth, Robert R

Journal of the American Medical Informatics Association | April 24, 2016 | Volume: 23 | Issue: 4 | Pages: 791-795

10.1093/jamia/ocv213 | PMID 27107452 Get It

AbstractThe recent announcement of the Precision Medicine Initiative by President Obama has brought precision medicine (PM) to the forefront for healthcare providers, researchers, regulators, innovators, and funders alike. As technologies continue to evolve and datasets grow in magnitude, a strong computational infrastructure will be essential to realize PM’s vision of improved healthcare derived from personal data. In addition, informatics research and innovation affords a tremendous opportunity to drive the science underlying PM. The informatics community must lead the development of technologies and methodologies that will increase the discovery and application of biomedical knowledge through close collaboration between researchers, clinicians, and patients. This perspective highlights seven key areas that are in need of further informatics research and innovation to support the realization of PM.
Surgical salvage of recurrent vestibular schwannoma following prior stereotactic radiosurgery
Wise, Stephanie C., Carlson, Matthew L. , Tveiten, Øystein Vesterli , Driscoll, Colin L. W., Myrseth, Erling , Lund‐Johansen, Morten , Link, Michael J. , Driscoll, Colin L.

The Laryngoscope | April 23, 2016 | Volume: 126 | Issue: 11 | Pages: 2580-2586

10.1002/lary.25943 | PMID 27107262 Get It

Objectives/HypothesisTo evaluate outcomes of salvage surgery for vestibular schwannoma (VS) that failed primary stereotactic radiosurgery (SRS).MethodsCase‐control study of 37 patients who underwent surgical resection of sporadic VS following prior SRS at two tertiary academic referral centers between 2003 and 2015. A cohort of nonirradiated control subjects, matched according to tumor size, age, and treatment center, were used as comparison.ResultsThirty‐seven patients were included. The median time from radiation to surgical salvage was 36 months (range 9.6–153 months). Following tumor progression after SRS, 18 (49%) patients underwent gross total resection, 10 (27%) underwent near‐total resection, and nine (24%) underwent subtotal resection. Postoperative complications following salvage surgery included one (3%) case of stroke, four (11%) cases of cerebrospinal fluid leak, and two (5%) cases of meningitis. Twenty‐seven (73%) patients had good postoperative facial nerve outcome (House‐Brackmann Score I–II) at long‐term follow‐up. There were no cases of tumor recurrence or regrowth after a median length of 26 months following microsurgical salvage (range 3–114 months). The rate of satisfactory postoperative facial nerve function was not different between study and control subjects (73% vs. 76%; P = 0.8); however, less‐than‐complete resection was utilized more frequently among previously radiated patients (P = 0.01).ConclusionMicrosurgical salvage of VS following primary radiation therapy is challenging. Less‐than‐complete resection is required in a greater percentage of patients to preserve facial nerve integrity and prevent neurological complications. Long‐term follow‐up is needed to determine the risk of delayed progression following incomplete tumor removal.Level of Evidence3b. Laryngoscope, 126:2580–2586, 2016
Targeting Prolactin Receptor (PRLR) Signaling in PRLR-Positive Breast and Prostate Cancer
O’Sullivan, Ciara C. , Bates, Susan E. , Bates, Susan E

The Oncologist | April 23, 2016 | Volume: 21 | Issue: 5 | Pages: 523-526

10.1634/theoncologist.2016-0108 | PMID 27107001 Get It

In this issue of The Oncologist, Agarwal et al. report negative results from a phase I trial of LFA102. Although “negative” in terms of antitumor activity, the study provides useful pharmacokinetic and pharmacodynamic information. Future trials evaluating PRLR blockers alone and in combination with other agents may still be warranted in patients with breast and prostate cancer.